These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18295073)

  • 21. Rapamycin enhances lifespan: at last, an advantage for transplant recipients?
    Geissler EK
    Nephrol Dial Transplant; 2009 Dec; 24(12):3623-5. PubMed ID: 19773418
    [No Abstract]   [Full Text] [Related]  

  • 22. Considerations in sirolimus use in the early and late post-transplant periods.
    Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
    Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the mammalian target of rapamycin pathway and the effect of rapamycin on target expression and cellular proliferation in osteosarcoma cells from dogs.
    Gordon IK; Ye F; Kent MS
    Am J Vet Res; 2008 Aug; 69(8):1079-84. PubMed ID: 18672974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of rapamycin in the induction of tolerogenic dendritic cells.
    Fischer R; Turnquist HR; Taner T; Thomson AW
    Handb Exp Pharmacol; 2009; (188):215-32. PubMed ID: 19031028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges.
    Christians U; Schmitz V; Schöning W; Bendrick-Peart J; Klawitter J; Haschke M; Klawitter J
    Ther Drug Monit; 2008 Apr; 30(2):151-8. PubMed ID: 18367974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repetitive stretch suppresses denervation-induced atrophy of soleus muscle in rats.
    Agata N; Sasai N; Inoue-Miyazu M; Kawakami K; Hayakawa K; Kobayashi K; Sokabe M
    Muscle Nerve; 2009 Apr; 39(4):456-62. PubMed ID: 19260063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirolimus does not reduce receptor-mediated endocytosis of albumin in proximal tubule cells.
    Mreich E; Coombes JD; Rangan GK
    Transplantation; 2007 Jan; 83(1):105-7. PubMed ID: 17220808
    [No Abstract]   [Full Text] [Related]  

  • 30. [To stay immature: the first step to tolerate?].
    Grosjean F
    G Ital Nefrol; 2008; 25(4):383. PubMed ID: 18663680
    [No Abstract]   [Full Text] [Related]  

  • 31. The ups and downs of sirolimus in kidney transplantation, and the importance of reporting negative findings.
    van Gelder T
    Neth J Med; 2007 Jan; 65(1):3-4. PubMed ID: 17293633
    [No Abstract]   [Full Text] [Related]  

  • 32. Diabetes after transplantation and sirolimus: what's the connection?
    Pavlakis M; Goldfarb-Rumyantzev AS
    J Am Soc Nephrol; 2008 Jul; 19(7):1255-6. PubMed ID: 18579636
    [No Abstract]   [Full Text] [Related]  

  • 33. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients.
    Sampson VB; Dunn SP; Rymeski B; Malatack J; Rong NH; Flynn L; Krueger LJ
    J Pediatr Surg; 2008 Jun; 43(6):1134-41. PubMed ID: 18558196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of symposium. Sirolimus in kidney transplantation.
    Schena FP
    Transplantation; 2009 Apr; 87(8 Suppl):S30-3. PubMed ID: 19384185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Wali RK; Weir MR
    Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery.
    Hsu HJ; Tian YC; Chen YC; Lai BC; Fang JT; Yang CW; Wu MS
    Ren Fail; 2008; 30(3):303-6. PubMed ID: 18350450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
    Ronellenfitsch MW; Brucker DP; Burger MC; Wolking S; Tritschler F; Rieger J; Wick W; Weller M; Steinbach JP
    Brain; 2009 Jun; 132(Pt 6):1509-22. PubMed ID: 19416948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics in solid organ transplantation: a transition from kinetics to dynamics.
    Kuypers DR
    Pharmacogenomics; 2012 Nov; 13(15):1679-83. PubMed ID: 23171332
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of rapamycin on lifespan in Drosophila.
    Harrison B; Tran TT; Taylor D; Lee SD; Min KJ
    Geriatr Gerontol Int; 2010 Jan; 10(1):110-2. PubMed ID: 20102391
    [No Abstract]   [Full Text] [Related]  

  • 40. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.